GLP-1 Medication Titration: When to Increase and When to Stay at Your Current Dose Lori Fauquier, APN-C, WHNP Feb 6, 2025 3 min read Updated: Jun 7, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized medical weight loss, helping individuals control cravings, regulate blood sugar, and achieve sustainable weight loss
Is oral semaglutide as effective as its injectable version
A systematic review of metabolomic dysregulation in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (Cfs/Me/Seid)
Nuche-BerenguerBLozanoDGutirrez-RojasIMorenoPMariosoMLEsbritPet al
Other challenges There are several other challenges inherent to GLP-1 drugs, including: Cost and accessibility: The high cost of many GLP-1 agonists remains a significant barrier for many patients, with some insurance plans not covering these medications, particularly for obesity management